Insider Transactions in Q1 2022 at Inmune Bio, Inc. (INMB)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 22
2022
|
James Kelly Ganjei Director |
BUY
Grant, award, or other acquisition
|
Direct |
17,793
+50.0%
|
$142,344
$8.43 P/Share
|
|
Mar 22
2022
|
David J Moss Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
17,793
+1.42%
|
$142,344
$8.43 P/Share
|
|
Mar 22
2022
|
Raymond Joseph Tesi President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
23,724
+1.54%
|
$189,792
$8.43 P/Share
|
|
Mar 22
2022
|
Mark William Lowdell Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
23,590
+1.55%
|
$188,720
$8.43 P/Share
|